C. İrkeç Et Al. , "Relapse and disability outcomes in patients with MS treated with fingolimod," Lancet Neurology , vol.11, no.5, pp.420-428, 2012
İrkeç, C. Et Al. 2012. Relapse and disability outcomes in patients with MS treated with fingolimod. Lancet Neurology , vol.11, no.5 , 420-428.
İrkeç, C., Radue, E., & Kappos, L., (2012). Relapse and disability outcomes in patients with MS treated with fingolimod. Lancet Neurology , vol.11, no.5, 420-428.
İrkeç, CEYLA, Ernst-Wilhelm Radue, And Ludwig Kappos. "Relapse and disability outcomes in patients with MS treated with fingolimod," Lancet Neurology , vol.11, no.5, 420-428, 2012
İrkeç, CEYLA Et Al. "Relapse and disability outcomes in patients with MS treated with fingolimod." Lancet Neurology , vol.11, no.5, pp.420-428, 2012
İrkeç, C. Radue, E. And Kappos, L. (2012) . "Relapse and disability outcomes in patients with MS treated with fingolimod." Lancet Neurology , vol.11, no.5, pp.420-428.
@article{article, author={CEYLA İRKEÇ Et Al. }, title={Relapse and disability outcomes in patients with MS treated with fingolimod}, journal={Lancet Neurology}, year=2012, pages={420-428} }